Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» November 2011
November 2011
Teva Pharmaceutical: Dividend Dynamo, or the Next Blowup?
Teva Pharmaceutical: Dividend Dynamo, or the Next Blowup?
Motley Fool
Teva Pharmaceuticals
Here's How Eli Lilly May Be Failing You
Here's How Eli Lilly May Be Failing You
Motley Fool
Eli Lilly
My Favorite Drug Company: Teva Pharmaceuticals
My Favorite Drug Company: Teva Pharmaceuticals
Seeking Alpha
Teva Pharmaceuticals
Has Merck Become the Perfect Stock?
Has Merck Become the Perfect Stock?
Motley Fool
Merck
Abbott Breakup Will Create Two Moaty Companies
Abbott Breakup Will Create Two Moaty Companies
Yahoo/Morningstar
Abbott Laboratories
AstraZeneca: Dirt Cheap Pharmaceutical Stock With A 6% Yield And Strong Technical Support
AstraZeneca: Dirt Cheap Pharmaceutical Stock With A 6% Yield And Strong Technical Support
Seeking Alpha
AstraZeneca
Ranbaxy Gains After Report It May Get U.S. Approval for Lipitor
Ranbaxy Gains After Report It May Get U.S. Approval for Lipitor
Bloomberg
Ranbaxy
Lipitor
generics
Pfizer
Pfizer, Bristol-Myers’ Eliquis Recommended by U.K. Cost Agency
Pfizer, Bristol-Myers’ Eliquis Recommended by U.K. Cost Agency
Bloomberg
Pfizer
Bristol-Myers Squibb
Eliquis
anti-clotting
UK switches over to Merck, Sanofi HPV vaccine
UK switches over to Merck, Sanofi HPV vaccine
Reuters
Merck
Sanofi
HPV
Gardasil
Cervarix
GSK
Medicis Reviews Purchase of Graceway Pharma
Medicis Reviews Purchase of Graceway Pharma
Yahoo/Zacks
Medicis
Graceway
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »